Professor & Chair
Department of Pharmaceutical Sciences
College of Pharmacy
Department of Pharmaceutical Sciences
College of Pharmacy
Office Phone: 305-760-7511
Office Hours: TBA
Northeast Ohio Medical University
Dr. Bishayee’s teaching interest and experience include various Pharm.D. courses, such as Pharmaceutics, Pharmacokinetics, Oncology, Pharmacognosy/Natural Products, and Nuclear Pharmacy.
The primary research interest and experience of Dr. Bishayee for nearly last two decades encompass cancer biology, cancer therapeutics, and cancer prevention. His laboratory is involved in examining chemopreventive and therapeutic effects of various medicinal plants, natural products, dietary and synthetic agents using various pre-clinical models of cancer, including breast and liver cancer, and associated mechanisms of action, especially anti-inflammatory and cell signal-modulatory effects. The various projects of Dr. Bishayee are funded by the National Institutes of Health as well as private pharmaceutical/biotechnological companies.
Sinha D, Biswas J, Nabavi SM, Bishayee, A. Tea phytochemicals for breast cancer prevention and intervention: From bench to bedside and beyond. Seminars in Cancer Biology – in press (2017)
Nagulapalli Venkata KC, Swaroop A, Bagchi D, Bishayee A. A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion. Molecular Nutrition and Food Research 61(6): (2017) doi: 10.1002/mnfr.201600950
Mandal A, Bhatia D, Bishayee A. Anti-inflammatory mechanism is involved in pomegranate-mediated prevention of breast cancer: Role of NF-kB and Nrf2 signaling pathways. Nutrients 9:436 (2017) doi: 10.3390/nu9050436
Bishayee A, Mandal A, Bhattacharyya P, Bhatia D. Pomegranate exerts chemoprevention of experimentally induced mammary tumorigenesis by suppression of cell proliferation and induction of apoptosis. Nutrition and Cancer 68:120-130 (2016)
Mondal A, Guria T, Maity TK, Bishayee A. A novel tetraenoic fatty acid isolated from Amaranthus spinosus inhibits proliferation and induces apoptosis of human liver cancer cells. International Journal of Molecular Sciences 17(10):1604 (2016)
Patel SM, Nagulapalli Venkata KC, Bhattacharyya P, Sethi G, Bishayee A. Potential of neem (Azadirachta indica L.) for prevention and treatment of oncologic diseases. Seminars in Cancer Biology 40-41:100-115 (2016)
Jia LY, Shanmugam MK, Sethi G, Bishayee A. Potential role of targeted therapies in the treatment of triple-negative breast cancer. Anti-Cancer Drugs 27:147-155 (2016)
Bishayee A, Haskell Y, Do C, Sivaraman Siveen K, Mohandas N, Sethi G, Stoner GD. Potential benefits of edible berries in the management of aerodigestive and gastrointestinal tract cancers: preclinical and clinical evidence. Critical Reviews in Food Science and Nutrition 56:1753-1775 (2016)
Sinha D, Dutta K, Ganguly KK, Biswas J, Bishayee A. A novel synthetic oleanane triterpenoid suppresses adhesion, migration and invasion of highly metastatic melanoma cells by modulating gelatinase signaling axis. Molecular Carcinogenesis 54:654-667 (2015)
Mandal A, Bishayee A. Trianthema portulacastrum Linn. displays anti-inflammatory responses during chemically induced rat mammary carcinogenesis through simultaneous and differential regulation of NF-kB and Nrf2 signaling pathways. International Journal of Molecular Sciences 16:2426-2445 (2015)
Invited talk: Anticancer drug development from natural products: Progress, pitfalls and promise. Institute of Pharmacy and Biochemistry, Johannes Gutenberg University, Mainz, Germany, November 14, 2017.
Plenary talk: Natural products for cancer prevention and therapy: Progress, pitfalls and promise. 2nd International Conference on Natural Products for Cancer Prevention and Therapy, Kayseri, Turkey, November 8-11, 2017.
Plenary talk: Pomegranate phytochemicals targets inflammatory signaling to confer prevention of mammary carcinogenesis. 2nd International Conference for Cancer Research and Targeted Therapy, Miami, FL, October 26-28, 2017.
Keynote talk: Pomegranate: A unique fruit with extraordinary cancer preventive and therapeutic potential. 1st International Conference on Clinical Trial and Innovative Therapeutics, Cape Town, South Africa, July 24-26, 2017.
Keynote talk: Traditional medicinal plants for cancer prevention and therapy: Progress and promise. Research Institute of World’s Ancient Traditions Cultures and Heritage, Khinjili, Roing, Arunachal Pradesh, India, July 16, 2017.
Invited talk: Anticancer drug discovery based on natural products: Progress, promise and challenges. Institute of Technology of Costa Rica, Cartago, Costa Rica, November 4, 2016.
Plenary talk: Prevention of mammary carcinogenesis by Trianthema portulacastrum: Preclinical evidence and molecular mechanisms. International Conference for Cancer Research and Targeted Therapy, Baltimore, MD, October 21-23, 2016.
Invited talk: Current affairs: Black currants in health and disease. 4th International Phytocosmetics and Phytotherapy Congress, Guatemala City, Guatemala, June 4-8, 2016.
Plenary talk: Dietary phytochemicals and cancer prevention. 1st International Conference on Natural Products for Cancer Prevention and Therapy, Istanbul, Turkey, August 31-September 2, 2015.
Young Investigator Award (Dublin Institute of Technology, Ireland)
Young Investigator Award (Indo-American Society of Nuclear Medicine)
Younger Scientist Award (Indian Chemical Society)
Young Scientist Award (National Science Council, Canada)
Editor-in-Chief, Journal of Natural Products in Cancer Prevention and Therapy
Associate Editor-in-Chief, World Journal of Gastroenterology
Associate Editor, BMC Complementary and Alternative Medicine
Guest Editor, Theme issue on Cancer Prevention and Therapy, Seminars in Cancer Biology
Guest Editor, Theme issue on liver cancer, Current Cancer Drug Targets
Guest Editor, Theme issue on chemoprevention, Current Pharmaceutical Biotechnology
Advisory Board member, Getting to Know Cancer